Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BayStar Capital was a San Francisco-based investment management firm that specialized in providing growth capital to small-cap public companies, primarily through Private Investment in Public Equity (PIPE) transactions. The firm was active across several sectors, with a significant portion of its portfolio dedicated to the life sciences, biotechnology, and medical technology industries. BayStar Capital III, L.P. was one of the firm's prominent investment vehicles used to fund these ventures during the late 1990s and early 2000s. Led by partners Lawrence Goldfarb and Steven McKelvey, the firm became well-known for its structured finance approach in the healthcare sector. BayStar eventually ceased active operations following the conclusion of its primary investment cycles and various regulatory matters involving its principals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BayStar Capital III.